-
Signature
-
/s/ Eric S. Whitaker, as Attorney-in-Fact
-
Stock symbol
-
TXG
-
Transactions as of
-
Feb 22, 2022
-
Transactions value $
-
-$28,294
-
Form type
-
4
-
Date filed
-
2/24/2022, 06:40 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TXG |
Class A Common Stock |
Sale |
-$28.3K |
-360 |
-0.22% |
$78.59 |
160K |
Feb 22, 2022 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
TXG |
Class B Common Stock |
Gift |
$0 |
-267K |
-8.9% |
$0.00 |
2.73M |
Feb 22, 2022 |
Class A Common Stock |
267K |
|
See footnote |
F2, F3 |
transaction |
TXG |
Class B Common Stock |
Gift |
$0 |
+134K |
|
$0.00 |
134K |
Feb 22, 2022 |
Class A Common Stock |
134K |
|
See footnote |
F2, F4 |
transaction |
TXG |
Class B Common Stock |
Gift |
$0 |
+134K |
|
$0.00 |
134K |
Feb 22, 2022 |
Class A Common Stock |
134K |
|
See footnote |
F2, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Scientific Officer and President